Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Renal Insufficiency, Chronic 1Non-alcoholic Fatty Liver Disease 1Liver Cirrhosis, Alcoholic 1Hypothermia 1Hepatitis C 1Hepatitis B 1Fibrosis 1End Stage Liver Disease 1Carcinoma, Hepatocellular 1Acute Kidney Injury 1

Interventions

entecavir 4lenvatinib 2Tenofovir 2Sorafenib 2Radiofrequency Ablation 2Lamivudine 2polysaccharide MGN3 1peginterferon alfa-2b 1peginterferon alfa-2a 1navitoclax 1menatetrenone 1lens intermediate filament proteins 1hepatitis B hyperimmune globulin 1adefovir dipivoxil 1adefovir 1Urinalysis 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Telbivudine 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiomics 1Polymorphism, Genetic 1Pharmaceutical Preparations 1PHY 906 1Nucleosides 1Nivolumab 1Interferons 1Hypothermia, Induced 1Hepatitis B Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis B × Hypothermia, Induced × Gastrointestinal × Clear all
NCT03534141 2025-05-16

MHALT

University of California, San Francisco

Phase NA Terminated
175 enrolled 19 charts
GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡